1. Home
  2. EPIX vs DIT Comparison

EPIX vs DIT Comparison

Compare EPIX & DIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPIX
  • DIT
  • Stock Information
  • Founded
  • EPIX 2009
  • DIT 1981
  • Country
  • EPIX Canada
  • DIT United States
  • Employees
  • EPIX N/A
  • DIT N/A
  • Industry
  • EPIX Biotechnology: Pharmaceutical Preparations
  • DIT Food Distributors
  • Sector
  • EPIX Health Care
  • DIT Consumer Discretionary
  • Exchange
  • EPIX Nasdaq
  • DIT Nasdaq
  • Market Cap
  • EPIX 75.9M
  • DIT 78.7M
  • IPO Year
  • EPIX N/A
  • DIT 1995
  • Fundamental
  • Price
  • EPIX $1.72
  • DIT $106.90
  • Analyst Decision
  • EPIX Hold
  • DIT
  • Analyst Count
  • EPIX 3
  • DIT 0
  • Target Price
  • EPIX $2.00
  • DIT N/A
  • AVG Volume (30 Days)
  • EPIX 68.7K
  • DIT 308.0
  • Earning Date
  • EPIX 08-04-2025
  • DIT 07-17-2025
  • Dividend Yield
  • EPIX N/A
  • DIT 0.71%
  • EPS Growth
  • EPIX N/A
  • DIT N/A
  • EPS
  • EPIX N/A
  • DIT 2.44
  • Revenue
  • EPIX N/A
  • DIT $2,221,421,072.00
  • Revenue This Year
  • EPIX N/A
  • DIT N/A
  • Revenue Next Year
  • EPIX N/A
  • DIT N/A
  • P/E Ratio
  • EPIX N/A
  • DIT $41.84
  • Revenue Growth
  • EPIX N/A
  • DIT 7.47
  • 52 Week Low
  • EPIX $1.40
  • DIT $94.92
  • 52 Week High
  • EPIX $7.88
  • DIT $166.00
  • Technical
  • Relative Strength Index (RSI)
  • EPIX 55.34
  • DIT 48.13
  • Support Level
  • EPIX $1.60
  • DIT $94.92
  • Resistance Level
  • EPIX $1.73
  • DIT $107.00
  • Average True Range (ATR)
  • EPIX 0.04
  • DIT 4.16
  • MACD
  • EPIX 0.00
  • DIT 0.25
  • Stochastic Oscillator
  • EPIX 76.50
  • DIT 72.30

About EPIX ESSA Pharma Inc.

ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.

About DIT AMCON Distributing Company

Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores, and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.

Share on Social Networks: